UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000003354
Receipt number R000004072
Scientific Title A phase II study of carboplatin plus pemetrexed followed by gefitinib for stage IIIB/IV non-small cell lung cancer with EGFR mutation
Date of disclosure of the study information 2010/03/23
Last modified on 2016/03/18 11:13:38

No. Disposal Last modified on Item of update
1 Insert 2010/03/18 17:44:01
2 Update 2015/03/18 10:02:57 Address
Address
TEL
Email
Address
Address
TEL
Email
Address
Address
TEL
Post marketing survey by drug manufacture etc., specified by Japanese law.
Address1
Tel1
3 Update 2015/03/18 10:06:04 Recruitment status
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
4 Update 2015/04/20 14:39:32 Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization
Organization
Division name
Address
Address
TEL
Email
5 Update 2016/03/18 11:13:38 Recruitment status
Publication of results